期刊文献+

血管紧张素Ⅱ/一氧化氮相互作用对心血管疾病发病的影响 被引量:1

下载PDF
导出
摘要 肾素-血管紧张素Ⅱ(AngⅡ)系统(RAS),特别是AngⅡ,在血压和体液电解质调节中起关键作用.如今,血管紧张素转化酶(ACE)抑制剂在心血管疾病治疗中所显示的有益效果越来越受到重视.
作者 符云峰
出处 《河北医药》 CAS 2002年第5期333-335,共3页 Hebei Medical Journal
  • 相关文献

参考文献24

  • 1[1]Raij L. Hypertension and cardiovascular risk factors. Hypertension, 2001,37[part2]: 767-773.
  • 2[2]Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest,1986,78:31-39.
  • 3[3]Ganten D,Hermann K,Unger T,et al. The tissue rennin-angiotensin systems:focus on brain angiotensin, adrenal gland and arterial wall. Clin Exp Hypertens, 1983,5:1099-1118.
  • 4[4]Navar LG, Imig JD, Zou L, et al. Intrarenal production of angiotensin Ⅱ . Semin Nephrol, 1997,17: 412-422.
  • 5[5]Awolest MA, Widmann MD, Sessa WC, et al. Cyclic strain increases endothelial nitric oxide synthase activity. Surgery, 1994,116:439-444.
  • 6[6]Hambrecht R, Wolf A, Gielen S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med, 2000,342: 454-460.
  • 7[7]Panza JA, Casino PR, Kilcoyne CM, et al. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation, 1993,87:1468-1474.
  • 8[8]Gaeta G, De Michele M, Cuomo S, et al. Arterial abnormalities in the offspring of patients with premature myocardial infarction. N Engl J Med, 2000, 343:840-846.
  • 9[9]Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature, 1995,377:239-242.
  • 10[10]Dzau VJ. Tissue angiotensin and pathobiology of vascular disease. Hypertension, 2001,37:1047-1052.

同被引文献13

  • 1Raij L. Role of the angiotensinⅡ-nitric oxide interaction[J]. Hypertension, 2001;37:767-73.
  • 2Bragulat E, de la Sierra A, Antonio MT, et al . Endothelial dysfunction in salt-sensitive essential hypertension[J]. Hypertension,2001;37( Part 2): 444-8.
  • 3Dzau V. Tissue angiotensin and pathobiology of vascular disease. A unifying hypothesis[J]. Hypertension, 2001;37:1047-52.
  • 4Hodge G, Ye VZ, Duggan KA. Salt-sensitive hypertension resulting from nitric oxide synthase inhibition is associated with loss of regulation of angiotensin II in the rat[J]. Exp Physiol, 2002;87:1-8.
  • 5Tan DY, Meng S,Cason GW, et al . Mechanisms of salt-sensitive hypertension: role of inducible nitric oxide synthase[J]. Am J Physiol Regul Integr Comp Physiol, 2000;279: R2297-303.
  • 6Ferri C, Bellini C, Desideri G, et al . Clustering of endothelial markers of vascular damage in human salt-sensitive hypertension: influence of dietary sodium load and depletion[J].Hypertension, 1998;32: 862-8.
  • 7Masuda H, Azuma H. Biological and pathophysiological roles of endogenous methylarginines as inhibitors of nitric oxide synthase[J]. Nippon Yakurigaku Zasshi, 2002;119: 29-35.
  • 8Ito A, Egashira K, Narishige T, et al . Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus[J]. Circ J, 2002;66: 811-5.
  • 9Dzau VJ. Tissue angiotensin and pathobiology of vascular disease[J]. Hypertension, 2001;37:1047-52.
  • 10Bode Boger SM, Muke J, Surdacki A, et al . Oral L-arginine improves endothelial function in healthy individuals older than 70 years[J]. Vasc Med, 2003;8: 77-81.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部